Preparation of liposomal doxorubicin-graphene nanosheet and evaluation of its in vitro anti-cancer effects

References

• Abraham, S.A., et al., 2005. The liposomal formulation of doxorubicin. Methods in enzymology, 391, 71–97.
   PubMed Web of Science ®Google Scholar
• Alyane, M., Barratt, G., and Lahouel, M., 2016. Remote loading of doxorubicin into liposomes by transmembrane pH gradient to reduce toxicity toward H9c2 cells. Saudi pharmaceutical journal, 24 (2), 165–175.
   PubMed Web of Science ®Google Scholar
• Bacon, M., Bradley, S.J., and Nann, T., 2014. Graphene Quantum Dots. Particle and particle systems characterization, 31 (4), 415–428.
   Web of Science ®Google Scholar
• Bangham, A., et al., 1967. Osmotic properties and water permeability of phospholipid liquid crystals. Chem. Phys. Lipids, 1 (3), 225–264.
   Google Scholar
• Chandrasekaran, A.R., et al., 2011. Invitro studies and evaluation of metformin marketed tablets-Malaysia. Journal of applied pharmaceutical science, 1, 214.
   Google Scholar
• Chatterjee, N., Eom, H.-J., and Choi, J., 2014. A systems toxicology approach to the surface functionality control of graphene–cell interactions. Biomaterials, 35 (4), 1109–1127.
   PubMed Web of Science ®Google Scholar
• Chen, Z., et al., 2011. Adsorption behavior of epirubicin hydrochloride on carboxylated carbon nanotubes. International journal of pharmaceutics, 405 (1–2), 153–161.
   PubMed Web of Science ®Google Scholar
• Frost, R., et al., 2012. Graphene oxide and lipid membranes: interactions and nanocomposite structures. Nano letters, 12 (7), 3356–3362.
   PubMed Web of Science ®Google Scholar
• Gao, Y., et al., 2013. Graphene oxide-based magnetic fluorescent hybrids for drug delivery and cellular imaging. Colloids and surfaces B: biointerfaces, 112, 128–133.
   PubMed Web of Science ®Google Scholar
• Gregoriadis, G. and Ryman, B.E., 1972. Fate of protein-containing liposomes injected into rats. An approach to the treatment of storage diseases. European journal of biochemistry, 24 (3), 485–491.
   PubMedGoogle Scholar
• Janes, K.A., et al., 2001. Chitosan nanoparticles as delivery systems for doxorubicin. Journal of controlled release, 73 (2–3), 255–267.
   PubMed Web of Science ®Google Scholar
• K. Khosravi Darani, M.R.M., 2011. nanoliposomes; therapeutic and industrial applications.
   Google Scholar
• Li, L., et al., 2013. Focusing on luminescent graphene quantum dots: current status and future perspectives. Nanoscale, 5 (10), 4015–4039.
   PubMed Web of Science ®Google Scholar
• Li, Y., et al., 2016. A graphene quantum dot (GQD) nanosystem with redox-triggered cleavable PEG shell facilitating selective activation of the photosensitiser for photodynamic therapy. RSC advances, 6 (8), 6516–6522.
   Web of Science ®Google Scholar
• Liao, Z.-X., et al., 2015. An AS1411 aptamer-conjugated liposomal system containing a bubble-generating agent for tumor-specific chemotherapy that overcomes multidrug resistance. Journal of controlled release, 208, 42–51.
   PubMed Web of Science ®Google Scholar
• Liu, G., et al., 2013. Transferrin modified graphene oxide for glioma-targeted drug delivery: in vitro and in vivo evaluations. ACS applied materials and interfaces, 5 (15), 6909–6914.
   PubMed Web of Science ®Google Scholar
• Liu, J., et al., 2012. Synthesis of phospholipid monolayer membrane functionalized graphene for drug delivery. Journal of materials chemistry, 22 (38), 20634–20640.
   Web of Science ®Google Scholar
• Luo, D., et al., 2016. Doxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release. Biomaterials, 75, 193–202.
   PubMed Web of Science ®Google Scholar
• Ma, M., et al., 2016. Theranostic liposomes containing conjugated polymer dots and doxorubicin for bio-imaging and targeted therapeutic delivery. RSC advances, 6 (3), 1945–1957.
   Web of Science ®Google Scholar
• Mayer, L.D., et al., 1990. Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients. Biochimica et biophysica acta (BBA)-biomembranes, 1025 (2), 143–151.
   PubMedGoogle Scholar
• Mozafari, R. M., 2005. Nanoliposomes: from fundamentals to recent developments. Trafford: Trafford Publishing.
   Google Scholar
• Niu, G., Cogburn, B., and Hughes, J., 2010. Preparation and characterization of doxorubicin liposomes. Cancer nanotechnology: methods and protocols, 624, 211–219.
   Google Scholar
• Noble, G.T., et al., 2014. Ligand-targeted liposome design: challenges and fundamental considerations. Trends in biotechnology, 32 (1), 32–45.
   PubMed Web of Science ®Google Scholar
• Orecchioni, M., et al., 2015. Graphene as cancer theranostic tool: progress and future challenges. Theranostics, 5 (7), 710.
   PubMed Web of Science ®Google Scholar
• Petros, R.A. and Desimone, J.M., 2010. Strategies in the design of nanoparticles for therapeutic applications. Nature reviews: drug discovery, 9 (8), 615–627.
   PubMed Web of Science ®Google Scholar
• Samadikhah, H.R., et al., 2011. Preparation, characterization, and efficient transfection of cationic liposomes and nanomagnetic cationic liposomes. International journal of nanomedicine, 6, 2275–2283.
   PubMed Web of Science ®Google Scholar
• Samadikhah, H.R., Nikkhah, M., and Hosseinkhani, S., 2016. Enhancement of cell internalization and photostability of red and green emitter quantum dots upon entrapment in novel cationic nanoliposomes. Luminescence, 32, 517–528.
   PubMed Web of Science ®Google Scholar
• Shen, J., et al., 2011. Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism. Nanoscale, 3 (10), 4314–4322.
   PubMed Web of Science ®Google Scholar
• Shen, J., et al., 2012. Graphene quantum dots: emergent nanolights for bioimaging, sensors, catalysis and photovoltaic devices. Chemical communications, 48 (31), 3686–3699.
   PubMed Web of Science ®Google Scholar
• Singh, V., et al., 2011. Graphene based materials: past, present and future. Progress in materials science, 56 (8), 1178–1271.
   Web of Science ®Google Scholar
• Wu, C., et al., 2013a. Insight into the cellular internalization and cytotoxicity of graphene quantum dots. Advanced healthcare materials, 2 (12), 1613–1619.
   PubMed Web of Science ®Google Scholar
• Wu, S., et al., 2013b. Adsorption properties of doxorubicin hydrochloride onto graphene oxide: equilibrium, kinetic and thermodynamic studies. Materials, 6 (5), 2026–2042.
   PubMed Web of Science ®Google Scholar
• Xu, M., et al., 2013. Hydrothermal/solvothermal synthesis of graphene quantum dots and their biological applications. Nano biomedicine and engineering, 5 (2), 65–71.
   Google Scholar
• Yang, Y., et al., 2013. Graphene based materials for biomedical applications. Materials today, 16 (10), 365–373.
   Web of Science ®Google Scholar
• Yi, Y., et al., 2005. A polymeric nanoparticle consisting of mPEG-PLA-Toco and PLMA-COONa as a drug carrier: improvements in cellular uptake and biodistribution. Pharmaceutical research, 22 (2), 200–208.
   PubMed Web of Science ®Google Scholar
• Zhang, L., et al., 2010. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small, 6 (4), 537–544.
   PubMed Web of Science ®Google Scholar
• Zhang, S., et al., 2011. In vitro and in vivo behaviors of dextran functionalized graphene. Carbon, 49 (12), 4040–4049.
   Web of Science ®Google Scholar
• Zhu, J.-J., et al., 2013. Quantum dots for DNA biosensing. Springer.
   Google Scholar